LONDON (ShareCast) - (Sharecast News) - Software developer Cambridge Cognition has won a £1.0m contract as the cognitive assessment partner for a late phase cancer trial.
Cambridge Cognition said on Friday that revenue from the contract, its second with a "top ten pharmaceutical company", was expected to be recognised over the next six years.

Chief executive Matthew Stork said: "This pharmaceutical client has a long-standing commitment to improving outcomes for cancer patients and we are delighted to be supporting their efforts.

"We expect that this could become a considerable growth area for Cambridge Cognition in the future."

As of 1030 BST, Cambridge Cognition shares were up 7.14% at 176.25p.

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE